Design, Synthesis, Molecular Modeling and Anti-Hyperglycemic Evaluation of Quinazoline-Sulfonylurea Hybrids as Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) and Sulfonylurea Receptor (SUR) Agonists
Open Access
- 24 August 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (17) , 9605
Abstract
New quinazoline-sulfonylurea hybrids were prepared and examined for their in vivo anti-hyperglycemic activities in STZ-induced hyperglycemic rats using glibenclamide as a reference drug. Compounds VI-6-a, V, IV-4, VI-4-c, IV-6, VI-2-a, IV-1, and IV-2 were more potent than the reference glibenclamide. They induced significant reduction in the blood glucose levels of diabetic rats: 78.2, 73.9, 71.4, 67.3, 62, 60.7, 58.4, and 55.9%, respectively, while the reference glibenclamide had 55.4%. Compounds IV-1, VI-2-a, IV-2, V, and IV-6 showed more prolonged antidiabetic activity than glibenclamide. Moreover, molecular docking and pharmacokinetic studies were performed to examine binding modes of the prepared compounds against peroxisome proliferator-activated receptor gamma (PPARγ). The highest active compounds exhibited good binding affinity with high free energy of binding against PPARγ. In silico absorption, distribution, metabolism, elimination and toxicity (ADMET) studies were performed to investigate pharmacokinetics and safety of the synthesized compounds. They showed considerable human intestinal absorption with low toxicity profile.Keywords
Funding Information
- King Abdulaziz University, Jeddah, Saudi Arabia (426/049)
This publication has 37 references indexed in Scilit:
- Synthesis of N-(5-chloro-6-(quinolin-3-yloxy)pyridin-3-yl)benzenesulfonamide derivatives as non-TZD peroxisome proliferator-activated receptor γ (PPARγ) agonistEuropean Journal of Medicinal Chemistry, 2012
- Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or HypoglycemiaDiabetes Care, 2008
- Streptozotocin-induced diabetes modulates GABA receptor activity of rat retinal neuronsExperimental Eye Research, 2007
- Teach your patient to administerNursing, 2007
- Inhaled insulinNursing, 2007
- Pharmacokinetic Interactions with ThiazolidinedionesClinical Pharmacokinetics, 2007
- Comparison of nateglinide and gliclazide in combination with metformin, for treatment of patients with Type 2 diabetes mellitus inadequately controlled on maximum doses of metformin aloneDiabetic Medicine, 2006
- New treatments for patients with type 2 diabetes mellitusPostgraduate Medical Journal, 1996
- Comparative Tolerability Profiles of Oral Antidiabetic AgentsDrug Safety, 1994
- Pyrimidine derivatives. VII. Structure-activity relationship of hypoglycemic 4-amino-2-(1-piperazinyl)pyrimidines investigated by the adaptive least-squares method.Chemical and Pharmaceutical Bulletin, 1983